Accordingly, CML cells where GSK-3β had been knocked down displayed higher levels of apoptosis relative to control cells upon treatment with IFN-γ [185]. The gene discussed is IFNG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.